The AVEX! token is the native transactional unit within the Aevolve Protocol. It is the primary asset for entry into the Aevolve ecosystem. Its role is defined under the rules of the Aevolve Protocol.
Users can use AVEX! to purchase tokenized vouchers or reservation certificates on BIOSPHERES. AVEX! also serves as a future voting reserve and incentive mechanism for both patients and medical experts signed up on the BIOSPHERES platform.
ERC-20 CONTRACT ADRESS
0x60ec6cb71bc7e21f366ab4b570dd3ff181814f7c
BEP-20 CONTRACT ADDRESS
0xea6c643b02ead1e42813771826e64a70a973f3e9
• SYMBOL AVEX!
• NOTICE: AVEX Token is no longer supported and is replaced by AVEX!
• MULTI-PROTOCOL - AVEX! Token is a multi-protocol Sub-Token under the AEVOLVE ERC-1155 Smart Contract. It also contains NFT (ERC-721) digital assets to represent several components of AEVOLVE’s medical innovation financing model.
• ERC-20 (Ethereum Mainnet) – AVEX! on ETHERSCAN
• BEP-20 (Binance Smart Chain) on BSCSCAN
• OPENING MINT: 1.21 Million Tokens (Airdrops and starting Liquidity Pools)
• MAX 35,000,000 AVEX! Mint Potential for Exclusive Access Smart Contracts
• MAX 35,000,000 AVEX! Biospheres Treasury Match Mint based on Exclusive Access Smart Contracts Activity (Time LOCKED for Biospheres Medical Offerings Use)
• DECLINING INFLATION RATE: Token Growth from Declining Inflation Rate released monthly based on 1% of Total Minted Supply while interest rate also reduces by 1% monthly. Inflationary supply to be allocated for project reinvestment and staking rewards (Staking features coming soon).
NOTE
Exclusive Access Smart Contracts incrementally mint a total based on 10% cumulative supply minted from an initial AVEX! 100K starting basis. The mint only is only activated once the previous 10% minted supply has been purchased.
The token value is driven by their utility in relation to the initial market offering available on the platform and the BIOSPHERES potential market offering. Aevolve’s market is designed to function primarily at a high utility value and minimize speculation over time. Aevolve is driven by actual medical solutions and products that address real-world demand and practical applications. AVEX! and SPHERE asset ownership are targeted towards patient-consumers.
The Aevolve Website serves for information purposes only and does not constitute research. This site and all materials, documents and information used therein or distributed in the context of its publication do not constitute or form part of and should not be construed as, an offer (public or private) or a solicitation of offers (public or private) to purchase or subscribe for or sell shares or other securities of the Company or any of its affiliates or subsidiaries in any jurisdiction or an inducement to enter into investment activity in any jurisdiction, and may not be used for such purposes.
This website may contain specific forward-looking statements, e.g. statements including terms like “believe”, “assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Aevolve or any of its affiliates or subsidiaries and those explicitly or implicitly presumed in these statements.
These factors include, but are not limited to: (1) general market, macroeconomic, governmental and regulatory trends, (2) movements in securities markets, exchange rates and interest rates and (3) other risks and uncertainties inherent in our business. Against the background of these uncertainties, you should not rely on forwardlooking statements. Neither the Company nor any of its affiliates or subsidiaries or their respective bodies, executives, employees and advisers assume any responsibility to prepare or disseminate any supplement, amendment, update or revision to any of the information, opinions or forward-looking statements contained in this website or to adapt them to any change in events, conditions or circumstances, except as required by applicable law or regulation.
Any – including only partial – reproduction of any article or picture included in this website is solely permitted based on an authorization from Aevolve. No responsibility is assumed in case of unsolicited delivery.